Nociceptors and mediators in acute inflammatory pain;Nocicepteurs et médiateurs dans la douleur aiguë inflammatoire

Annales Francaises d'Anesthesie et de Reanimation

Volumn 21, Issue 4, 2002, Pages 315-335

  Le Bars, D ^a   Adam, F ^a,b  

^a INSERM   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

Author keywords

Acute pain; Inflammation; Nociceptors; Pain

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; BONE DERIVED GROWTH FACTOR; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL; CYTOKINE; HISTAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KALLIDIN; KININ DERIVATIVE; LEUKOTRIENE; LEUKOTRIENE B4; LIPOXYGENASE; NERVE GROWTH FACTOR; NEUROKININ A; NEUROTROPIN; NITRIC OXIDE; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTANOID; PROTEINASE; SEROTONIN; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

CONTROLLED STUDY; INFLAMMATION; MEDIATOR RELEASE; NERVE CELL NETWORK; NOCICEPTION; NONHUMAN; PAIN; PATHOPHYSIOLOGY; PRESYNAPTIC INHIBITION; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION;

EID: 0036257404     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(02)00592-0     Document Type: Short Survey

References (144)

1. The mammalian sodium channel BNC1 is required for normal touch sensation
2. The molecules of mechanosensation
3. What is a noxious stimulus?
4. Psychophysiology of experimentally induced pain
5. Primitivism and plasticity of pain-implication of polymodal receptors
6. Injury-related behavior and neuronal plasticity, an evolutionary perspective on sensitization, hyperalgesia, and analgesia
7. Peptide- and non-peptide-containing unmyelinated primary afferents, the parallel processing of nociceptive information
8. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry
9. IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life
10. The non-peptide NK1 receptor antagonist SR 140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats
11. Primary afferent tachykinins are required to experience moderate to intense pain
12. The GDNF family ligands and receptors -implications for neural development
13. Isolectin (4) -positive and -negative nociceptors are functionally distinct
14. Distinct neurochemical features of acute and persistent pain
15. Inflammation-induced up-regulation of protein kinase Cγ immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing
16. Ion channels gated by heat
17. Capsaicin, protons and heat, new excitement about nociceptors
18. Novel natural vanilloid receptor agonists, new therapeutic targets for drug development
19. Vanilloid (Capsaicin) receptors and mechanisms
20. Actions of capsaicin on sensory receptors
21. Similarities and differences between the responses of rat sensory neurons to noxious heat and capsaicin
22. The capsaicin receptor, a heat-activated ion channel in the pain pathway
23. The cloned capsaicin receptor integrates multiple pain-producing stimuli
24. Potentiation of the capsaicin receptor determined by a key extracellular site
25. Temperature coefficient of membrane currents induced by noxious heat in sensory neurones in the rat
26. A capsaicin-receptor homologue with a high threshold for noxious heat
27. Noxious heat activates all capsaicin-sensitive and also a sub-population of capsaicin-insensitive dorsal root ganglion neurons
28. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances
29. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
30. New perspectives on enigmatic vanilloid receptors
31. Induction of vanilloid receptor channel activity by protein kinase C
32. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
33. Molecular physiology of proton transduction in nociceptors
34. A proton-gated cation channel involved in acidsensing
35. Tissue acidosis in nociception and pain
36. A sensory neuron-specific, proton-gated ion channel
37. P2X receptors mediate ATP-induced primary nociceptive neurone activation
38. ATP, P2X receptors and pain pathways
39. ATP as a peripheral mediator of pain
40. Purine-mediated signalling in pain and visceral perception
41. Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia
42. The molecular pathophysiology of pain: Abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons
43. Involvement of Na+ channels in pain pathways
44. Voltage-gated sodium channels
45. The neuron as a dynamic electrogenic machine: Modulation of sodium-channel expression as a basis for functional plasticity in neurons
46. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons
47. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia
48. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy
49. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons
50. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
51. Alpha-SNS produces the slow TTX-resistant sodium current in large cutaneous afferent DRG neurons
52. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro
53. Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels
54. Molecular mechanisms of local anesthesia: A review
55. Non-opioid postoperative analgesia
56. Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms
57. Effect of preemptive nerve block on inflammation and hyperalgesia after human thermal injury
58. The effect of a sciatic nerve block on the development of inflammation in carrageenan injected rats
59. SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model
60. Silent and active nociceptors, structures, functions and clinical implications
61. Kinins and their receptors in hyperalgesia
62. Kinins in pain and inflammation
63. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat
64. Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C
65. The B1-agonist [des-Arg10] -kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts
66. B1 receptors as a new inflammatory target. Could this B the 1?
67. The B1 receptors for kinins
68. Hyperalgesia from subcutaneous cytokines
69. Circulating interleukin-6 mediates the febrile response to localised inflammation in rats
70. Cyclooxygenase-dependent signalling: Molecular events and consequences
71. Cyclooxygenases: Structural, cellular, and molecular biology
72. Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future
73. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis
74. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis The CLASS STUDY: A randomized, controlled trial
75. The coxibs, selective inhibitors of cyclooxygenase-2
76. The role of IP prostanoid receptors in inflammatory pain
77. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons
78. The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: Whole-cell and single-channel studies
79. The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones
80. Phorbol ester-induced inhibition of potassium currents in rat sensory neurons requires voltage-dependent entry of calcium
81. Nitric oxide signaling in pain and nociceptor sensitization in the rat
82. NOS inhibitor antagonism of PGE2-induced mechanical sensitization of cutaneous C-fiber nociceptors in the rat
83. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2
84. New insights into the role of COX 2 in inflammation
85. Inducible cyclooxygenase may have anti-inflammatory properties
86. Resolution of inflammation
87. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
88. Activators and target genes of Rel/NF-κB transcription factors
89. κ NF. B as a therapeutic target in chronic inflammation: Recent advances
90. κ NF. B in neuronal plasticity and neurodegenerative disorders
91. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkappaB kinase-beta
92. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
93. Interleukin-4-dependent production of PPARgamma ligands in macrophages by 12/15-lipooxygenase
94. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis
95. Development of pharmacological agents for targeting neurotrophins and their receptors
96. Effects of trkB and trkC neurotrophin receptor agonists on thermal nociception: A behavioural and electrophysiological study
97. Neurotrophins, nociceptors, and pain
98. Neurotrophins and hyperalgesia
99. Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin
100. Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord
101. Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system
102. Nerve growth factor treatment increases brainderived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord
103. BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABAA receptor surface expression
104. Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord
105. Neurotrophins: Peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity
106. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors
107. Substance P
108. Protease-activated receptors: Sentries for inflammation?
109. Protease-activated receptors in inflammation, neuronal signaling and pain
110. Peripheral excitatory amino acids
111. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors
112. Protein kinase subtypes involved in injury-induced nociception
113. Cannabinoid receptors and pain
114. N (2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by downmodulating mast cell activation
115. Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
116. Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV 1-driven proenkephalin A overexpressing rats
117. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overeproduction in sensory neurons
118. The control of pain in peripheral tissue by opioids
119. Pain relief from intra-articular morphine after knee surgery: A qualitative systematic review
120. Intraarticular morphine versus dexamethasone in chronic arthritis
121. Transcriptional and posttranslational plasticity and the generation of inflammatory pain
122. Role of protein kinase A in the maintenance of inflammatory pain
123. Calcium channel blockers and pain therapy
124. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia
125. 2+ channels
126. 2δ subunit of voltage dependent calcium channels in models of neuropathic pain
127. Transmitters involved in antinociception in the spinal cord
128. The spinal biology in humans and animals of pain states generated by persistent small afferent input
129. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord
130. Sensitization of pain pathways in the spinal cord: Cellular mechanisms
131. The glutamate receptor ion channels
132. Glycine potentiates the NMDA response in cultured mouse brain neurons
133. Src, a molecular switch governing gain control of synaptic transmission mediated by N-methyl-D-aspartate receptors
134. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin-a double-blind, placebo-controlled, human experimental study
135. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: A double-blind, cross-over comparison with morphine and placebo
136. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery
137. Pharmacology and functions of metabotropic glutamate receptors
138. New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors
139. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation
140. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P
141. NK1 (substance P) receptor antagonists - Why are they not analgesic in humans?
142. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
143. Null mutations lacking substance: Elucidating pain mechanisms by genetic pharmacology
144. Balanced analgesia: What is it and what are its advantages in postoperative pain?